AC Immune: KOL Webinar on Vaccination to Treat and Prevent Alzheimer’s and Parkinson’s Diseases
About The Event
The webinar will feature a presentation from Key Opinion Leader (KOL) Cynthia A. Lemere, Ph.D., of the Ann Romney Center for Neurologic Diseases at Brigham & Women’s Hospital.
During her presentation, Dr. Lemere will discuss the current immunotherapy landscape and novel therapeutic approaches to treat and prevent neurodegenerative diseases, with a focus on biomarkers and target proteins for active vaccination approaches.
Additionally, members of AC Immune’s management team will provide an overview of the Company’s precision medicine approach, industry-leading pipeline of active vaccines, and the advantages offered by the innovative biomarker-based clinical trial designs being utilized in its Alzheimer’s and Parkinson’s disease programs.
A live question and answer session will follow the formal presentations.